Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in Euvolemic and Hypervolemic Hyponatremia
NCT04447911Phase 4Completed
- Sponsor
- University Hospital Basel
- Start
- Feb 2021
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of empagliflozin in hyponatremia, sponsored by University Hospital Basel. Started Feb 2021; status: completed.
02
Drugs
empagliflozin
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT04447911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447911.